mediapro

The Long Case for Pfizer

And BRK.A is simply a perfect fundamental model, not technical approach to choosing companies with a rather broad representation of the overall market.

Malkiel never suggests that everyone need take a total stock market investing approach. There will always be those -- sadly with me included -- who believe that they can outperform the total market. Historicallt, of course, that's wrong. More than 80% of active mutual fund managers regularly underperform the 5000.

He simply observes that chartists and their green-eye-shade myopics come and go, but that the efficient market theory is the best explanation for how the stock market works.